Evidence map›Paper›PMID 35222077›Full record

ArticleFrontiers in physiology2022

Visceral Adiposity, Inflammation, and Testosterone Predict Skeletal Muscle Mitochondrial Mass and Activity in Chronic Spinal Cord Injury.

Jacob A Goldsmith, Raymond E Lai, Ryan S Garten, Qun Chen, Edward J Lesnefsky, Robert A Perera, Ashraf S Gorgey

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02660073 (Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02660073 nacompletednot on this map

Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury

TypeinterventionalSponsorUnited States Department of DefenseRan2015 to 2020Enrolled48ConditionsSpinal Cord InjuriesArmsNMES+FES, Control+FES
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jacob A GoldsmithSpinal Cord Injury and Disorders, Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC), Richmond, VA, United States.
Raymond E LaiSpinal Cord Injury and Disorders, Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC), Richmond, VA, United States.
Ryan S GartenDepartment of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, VA, United States.
Qun ChenMedical Service, Hunter Holmes McGuire VA Medical Center, Richmond, VA, United States.
Edward J LesnefskyMedical Service, Hunter Holmes McGuire VA Medical Center, Richmond, VA, United States.
Robert A PereraDepartment of Biostatistics, Virginia Commonwealth University, Richmond, VA, United States.
Ashraf S GorgeySpinal Cord Injury and Disorders, Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC), Richmond, VA, United States.
Hunter Holmes McGuire VA Medical Center · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitochondrial health is an important predictor of several health-related comorbidities including obesity, type 2 diabetes mellitus, and cardiovascular disease. In persons with spinal cord injury (SCI), mitochondrial health has been linked to several important body composition and metabolic parameters. However, the complex interplay of how mitochondrial health is affected has yet to be determined in this population.

objectiveIn this study, we examined the contribution of visceral adiposity, inflammatory biomarkers, testosterone and circulating serum growth factors as predictors of mitochondrial health in persons with chronic SCI.

participantsThirty-three individuals with chronic SCI (

methodsVisceral adipose tissue (VAT) was measured via magnetic resonance imaging (MRI). After an overnight fast, serum testosterone, inflammatory biomarkers [interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), c-reactive protein (CRP)], and anabolic growth factors [insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3)] were measured. Skeletal muscle biopsies were obtained from the vastus lateralis muscle to measure citrate synthase (CS) and Complex III activity. Regression analyses were used to examine predictors of mitochondrial mass and activity.

resultsCS activity was negatively associated with VAT (

conclusionIncreased visceral adiposity and associated inflammatory signaling (CRP) along with reduced testosterone levels predict mitochondrial dysfunction following SCI. Specifically, lower VAT CLINICAL

trial registration[www.ClinicalTrials.gov], identifier: [NCT02660073].

Indexed as

growth factorsinflammationmitochondriaspinal cord injurytestosteronevisceral adipose tissue

Identifiers

PMID35222077
PMCPMC8867006
OpenAlexW4211073424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.